Characterization of C-strain "Riems" TAV-epitope escape variants obtained 
through selective antibody pressure in cell culture

Leifer, I.; Blome, S.; Blohm, U.; Konig, P.; Kuster, H.; Lange, B.; Beer, M.

doi:10.1186/1297-9716-43-33

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture

MPS-Authors

/persons/resource/persons50403

Lange, B.
Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Leifer.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Leifer, I., Blome, S., Blohm, U., Konig, P., Kuster, H., Lange, B., et al. (2012). Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture. Veterinary Research, 43(1): 33. doi:10.1186/1297-9716-43-33.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-F060-4

Abstract

ABSTRACT: Classical swine fever virus (CSFV) C-strain "Riems" escape variants generated under selective antibody pressure with monoclonal antibodies and a peptide-specific antiserum in cell culture were investigated. Candidates with up to three amino acid exchanges in the immunodominant and highly conserved linear TAV-epitope of the E2-glycoprotein, and additional mutations in the envelope proteins ERNS and E1, were characterized both in vitro and in vivo.It was further demonstrated, that intramuscular immunization of weaner pigs with variants selected after a series of passages elicited full protection against lethal CSFV challenge infection. These novel CSFV C-strain variants with exchanges in the TAV-epitope present potential marker vaccine candidates. The DIVA (differentiating infected from vaccinated animals) principle was tested for those variants using commercially available E2 antibody detection ELISA. Moreover, direct virus differentiation is possible using a real-time RT-PCR system specific for the new C-strain virus escape variants or using differential immunofluorescence staining.